FLJ11730 Antibody - N-terminal region

Artikelnummer: ASB-ARP33354_P050
Artikelname: FLJ11730 Antibody - N-terminal region
Artikelnummer: ASB-ARP33354_P050
Hersteller Artikelnummer: ARP33354_P050
Alternativnummer: ASB-ARP33354_P050-25UL,ASB-ARP33354_P050-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: IHC, WB
Spezies Reaktivität: Bovine, Human, Mouse, Rat, Zebrafish
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human FLJ11730
Alternative Synonym: EAF6, CENP-28, C1orf149, NY-SAR-91
The screening of cDNA expression libraries from human tumors with serum antibody (SEREX) has proven to be a powerful method for identifying the repertoire of tumor antigens recognized by the immune system of cancer patients, referred to as the cancer immunome. In this regard, cancer/testis (CT) antigens are of particular interest because of their immunogenicity and restricted expression patterns. Synoivial sarcomas are striking with regard to CT antigen expression, however, highly expressed in sarcoma, CT antigens do not induce frequent humoral immune responses in sarcoma patients. Sera from two patients were used to immunoscreen cDNA libraries from two synovial sarcoma cell lines and normal testis, resulting in the identification of 113 distinct antigens. Sarcoma antigen NY-SAR-91 is one of them.
Klonalität: Polyclonal
Konzentration: 0.5 mg/ml
Molekulargewicht: 23kDa
NCBI: 64769
UniProt: Q86WE3
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Human kidney
WB Suggested Anti-FLJ11730 Antibody Titration: 0.2-1 ug/ml
ELISA Titer: 1:312500
Positive Control: Jurkat cell lysateMEAF6 is supported by BioGPS gene expression data to be expressed in Jurkat
FLJ11730 antibody - N-terminal region (ARP33354_P050) in Human Jurkat using Western Blot